Published in:

01-08-2004

HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel

Authors: A. Di Leo, S. Chan, M. Paesmans, K. Friedrichs, T. Pinter, V. Cocquyt, E. Murray, I. Bodrogi, E. Walpole, B. Lesperance, S. Korec, J. Crown, P. Simmonds, G. Von Minckwitz, J.Y. Leroy, V. Durbecq, J. Isola, M. Aapro, M.J. Piccart, D. Larsimont

Published in: Breast Cancer Research and Treatment | Issue 3/2004